Engineered human vascularized constructs accelerate diabetic wound healing

Biomaterials

Volumn 102, Issue , 2016, Pages 107-119

  Shen, Yu I ^a   Cho, Hongkwan ^b   Papa, Arianne E ^a,c   Burke, Jacqueline A ^a,c   Chan, Xin Yi ^a   Duh, Elia J ^b   Gerecht, Sharon ^a  

^a Johns Hopkins University   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Johns Hopkins University   (United States)

Author keywords

Hyaluronan; Hydrogel; Induced pluripotent stem cell; Type 1 diabetes; Wound healing

Indexed keywords

CELLS; CYTOLOGY; ENDOTHELIAL CELLS; HYDROGELS; PATIENT TREATMENT;

CELLULAR DIFFERENTIATION; ENDOTHELIAL PROGENITOR; HUMAN-INDUCED PLURIPOTENT STEM CELLS; HYALURONAN; INDUCED PLURIPOTENT STEM CELLS; MACROPHAGE INFILTRATIONS; TYPE 1 DIABETES; WOUND HEALING;

STEM CELLS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL INFILTRATION; COLONY FORMING CELL; CONTROLLED STUDY; DIABETIC PATIENT; ENDOTHELIAL COLONY FORMING CELL; ENDOTHELIAL PROGENITOR CELL; HUMAN; HUMAN CELL; HYDROGEL; INDUCED PLURIPOTENT STEM CELL; INSULIN DEPENDENT DIABETES MELLITUS; MACROPHAGE; MICROVASCULATURE; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; NUCLEAR REPROGRAMMING; PRIORITY JOURNAL; REPERFUSION; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; TISSUE ENGINEERING; VASCULARIZATION; WOUND CLOSURE; WOUND HEALING; ANGIOGENESIS; ANIMAL; CELL LINE; CHEMISTRY; COMPLICATION; CYTOLOGY; DIABETIC COMPLICATION; DISEASE MODEL; ENDOTHELIUM CELL; EXPERIMENTAL DIABETES MELLITUS; FEMALE; NUDE MOUSE; PROCEDURES; STEM CELL TRANSPLANTATION; TISSUE SCAFFOLD; TRANSPLANTATION;

HYALURONIC ACID; POLYETHYLENE GLYCOL DIMETHACRYLATE HYDROGEL;

ANIMALS; CELL LINE; DIABETES COMPLICATIONS; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; FEMALE; HUMANS; HYALURONIC ACID; HYDROGEL, POLYETHYLENE GLYCOL DIMETHACRYLATE; INDUCED PLURIPOTENT STEM CELLS; MICE, NUDE; NEOVASCULARIZATION, PHYSIOLOGIC; STEM CELL TRANSPLANTATION; TISSUE SCAFFOLDS; WOUND HEALING;

EID: 84975520101     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2016.06.009     Document Type: Article

References (52)

1. [1] Wu, S.C., et al. Foot ulcers in the diabetic patient, prevention and treatment. Vasc. Health Risk Manag. 3:1 (2007), 65–76.
2. [2] American Diabetes, A, Economic costs of diabetes in the U.S. in 2012. Diabetes Care 36:4 (2013), 1033–1046.
3. [3] Gurtner, G.C., et al. Wound repair and regeneration. Nature 453:7193 (2008), 314–321.
4. [4] Tredget, E.E., The basis of fibrosis and following thermal injury wound healing disorders. J. Trauma-Injury Infect. Crit. Care, 62(6), 2007 S69–S69.
5. [5] Li, J., Zhang, Y.-P., Kirsner, R.S., Angiogenesis in wound repair: angiogenic growth factors and the extracellular matrix. Microsc. Res. Tech. 60:1 (2003), 107–114.
6. [6] Bannon, P., et al. Diabetes induces stable intrinsic changes to myeloid cells that contribute to chronic inflammation during wound healing in mice. Dis. Model Mech. 6:6 (2013), 1434–1447.
7. [7] Brosius, F.C. 3rd, et al. Mouse models of diabetic nephropathy. J. Am. Soc. Nephrol. 20:12 (2009), 2503–2512.
8. [8] Yiu, K.H., Tse, H.F., Specific role of impaired glucose metabolism and diabetes mellitus in endothelial progenitor cell characteristics and function. Arterioscler. Thromb. Vasc. Biol. 34:6 (2014), 1136–1143.
9. [9] Loomans, C.J.M., et al. Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes. Diabetes 53:1 (2004), 195–199.
10. [10] Ravi, S., Chaikof, E.L., Biomaterials for vascular tissue engineering. Regen. Med. 5:1 (2010), 107–120.
11. [11] Madeddu, P., Therapeutic angiogenesis and vasculogenesis for tissue regeneration. Exp. Physiol. 90:3 (2005), 315–326.
12. [12] Hanjaya-Putra, D., et al. Controlled activation of morphogenesis to generate a functional human microvasculature in a synthetic matrix. Blood 118:3 (2011), 804–815.
13. [13] Hanjaya-Putra, D., et al. Integration and regression of implanted engineered human vascular networks during deep wound healing. Stem Cells Transl. Med. 2:4 (2013), 297–306.
14. [14] Kusuma, S., et al. Self-organized vascular networks from human pluripotent stem cells in a synthetic matrix. Proc. Natl. Acad. Sci. U. S. A. 110:31 (2013), 12601–12606.
15. [15] Kusuma, S., Facklam, A., Gerecht, S., Characterizing human pluripotent-stem-cell-derived vascular cells for tissue engineering applications. Stem Cells Dev. 24:4 (2015), 451–458.
16. [16] Dulmovits, B.M., Herman, I.M., Microvascular remodeling and wound healing: a role for pericytes. Int. J. Biochem. Cell Biol. 44:11 (2012), 1800–1812.
17. [17] Chan, X., et al. Three-dimensional vascular network assembly from diabetic patient-derived induced pluripotent stem cells. Arterioscler. Thromb. Vasc. Biol. 35:12 (2015), 2677–2685.
18. [18] Barreto-Ortiz, S.F., et al. Fabrication of 3-dimensional multicellular microvascular structures. FASEB J. 29:8 (2015), 3302–3314.
19. [19] Khetan, S., Burdick, J., Cellular encapsulation in 3D hydrogels for tissue engineering. J. Vis. Exp., 32, 2009.
20. [20] Khetan, S., Chung, C., Burdick, J.A., Tuning hydrogel properties for applications in tissue engineering. Conf. Proc. IEEE Eng. Med. Biol. Soc. 2009 (2009), 2094–2096.
21. [21] Alpers, C.E., Hudkins, K.L., Mouse models of diabetic nephropathy. Curr. Opin. Nephrol. Hypertens. 20:3 (2011), 278–284.
22. [22] Breyer, M.D., et al. Mouse models of diabetic nephropathy. J. Am. Soc. Nephrol. 16:1 (2005), 27–45.
23. [23] Dunn, L., et al. Murine model of wound healing. J. Vis. Exp., 75, 2013, e50265.
24. [24] Duscher, D., et al. Transdermal deferoxamine prevents pressure-induced diabetic ulcers. Proc. Natl. Acad. Sci. U. S. A. 112:1 (2015), 94–99.
25. [25] Martinez-Santamaria, L., et al. The regenerative potential of fibroblasts in a new diabetes-induced delayed humanised wound healing model. Exp. Dermatol 22:3 (2013), 195–201.
26. [26] Wu, K.K., Huan, Y., Streptozotocin-induced diabetic models in mice and rats. Curr. Protoc. Pharmacol., 2008 Chapter 5: p. Unit 5 47.
27. [27] Sun, G., et al. Dextran hydrogel scaffolds enhance angiogenic responses and promote complete skin regeneration during burn wound healing. Proc. Natl. Acad. Sci. U. S. A. 108:52 (2011), 20976–20981.
28. [28] Shen, Y.I., et al. Acellular hydrogels for regenerative burn wound healing: translation from a porcine model. J. Invest Dermatol 135:10 (2015), 2519–2529.
29. [29] Schneider, A., Garlick, J.A., Egles, C., Self-assembling peptide nanofiber scaffolds accelerate wound healing. PLoS One, 3(1), 2008, e1410.
30. [30] Carretero, M., et al. In vitro and in vivo wound healing-promoting activities of human cathelicidin LL-37. J. Invest Dermatol 128:1 (2008), 223–236.
31. [31] Marrotte, E.J., et al. Manganese superoxide dismutase expression in endothelial progenitor cells accelerates wound healing in diabetic mice. J. Clin. Invest 120:12 (2010), 4207–4219.
32. [32] Tellechea, A., et al. Increased skin inflammation and blood vessel density in human and experimental diabetes. Int. J. Low. Extrem Wounds 12:1 (2013), 4–11.
33. [33] Cho, H., et al. Regulation of endothelial cell activation and angiogenesis by injectable peptide nanofibers. Acta Biomater. 8:1 (2012), 154–164.
34. [34] Hurley, J.R., et al. Nanofiber microenvironment effectively restores angiogenic potential of diabetic endothelial cells. Adv. Wound Care (New Rochelle) 3:11 (2014), 717–728.
35. [35] Sherratt, J.A., Murray, J.D., Models of epidermal wound healing. Proc. Biol. Sci. 241:1300 (1990), 29–36.
36. [36] Tabatabai, M.A., Eby, W.M., Singh, K.P., Hyperbolastic modeling of wound healing. Math. Comput. Model. 53:5–6 (2011), 755–768.
37. [37] Cukjati, D., et al. Modelling of chronic wound healing dynamics. Med. Biol. Eng. Comput. 38:3 (2000), 339–347.
38. [38] Fusi, L., Macroscopic models for fibroproliferative disorders: a review. Math. Comput. Model. 50:9–10 (2009), 1474–1494.
39. [39] Graham, M.L., et al. The streptozotocin-induced diabetic nude mouse model: differences between animals from different sources. Comp. Med. 61:4 (2011), 356–360.
40. [40] Galiano, R.D., et al. Quantitative and reproducible murine model of excisional wound healing. Wound Repair Regen. 12:4 (2004), 485–492.
41. [41] Wang, X., et al. The mouse excisional wound splinting model, including applications for stem cell transplantation. Nat. Protoc. 8:2 (2013), 302–309.
42. [42] Fang, R.C., et al. Limitations of the db/db mouse in translational wound healing research: is the NONcNZO10 polygenic mouse model superior?. Wound Repair Regen. 18:6 (2010), 605–613.
43. [43] Zou, J., et al. Gene targeting of a disease-related gene in human induced pluripotent stem and embryonic stem cells. Cell Stem Cell 5:1 (2009), 97–110.
44. [44] Liang, G., Zhang, Y., Genetic and epigenetic variations in iPSCs: potential causes and implications for application. Cell Stem Cell 13:2 (2013), 149–159.
45. [45] Rajasekar, P., et al. Epigenetic changes in endothelial progenitors as a possible cellular basis for glycemic memory in diabetic vascular complications. J. Diabetes Res., 2015, 2015, 436879.
46. [46] Martino, M.M., et al. Growth factors engineered for super-affinity to the extracellular matrix enhance tissue healing. Science 343:6173 (2014), 885–888.
47. [47] Greenhalgh, D.G., The role of apoptosis in wound healing. Int. J. Biochem. Cell Biol. 30:9 (1998), 1019–1030.
48. [48] Anderson, J.M., Rodriguez, A., Chang, D.T., Foreign body reaction to biomaterials. Semin. Immunol. 20:2 (2008), 86–100.
49. [49] Li, L., et al. Biodegradable and injectable in situ cross-linking chitosan-hyaluronic acid based hydrogels for postoperative adhesion prevention. Biomaterials 35:12 (2014), 3903–3917.
50. [50] Badylak, S.F., et al. Macrophage phenotype as a determinant of biologic scaffold remodeling. Tissue Eng. Part A 14:11 (2008), 1835–1842.
51. [51] Kyselova, P., et al. Hyperinsulinemia and oxidative stress. Physiol. Res. 51:6 (2002), 591–595.
52. [52] Yan, J., et al. Recovery from hind limb ischemia is less effective in type 2 than in type 1 diabetic mice: roles of endothelial nitric oxide synthase and endothelial progenitor cells. J. Vasc. Surg. 50:6 (2009), 1412–1422.